Dashboard
Program Home
WTC 2025 Website
Login
Dashboard
Program Home
WTC 2025 Website
Login
From Pre-Clinical Studies to First in Human: What's New on the Horizon
Tuesday August 05, 2025 - 16:30 to 17:45
Room: 12
34.8 Novel Anti-CD94 Treatment Reduces Kidney Ischemia-Reperfusion Injury and Subsequent Acute Lung Injury
Log in to add to favorites
Add Personal Notes
Daniel Calabrese, United States
Presentations by Daniel Calabrese
Tue-05 from 16:30 - 17:45 in room 12
From Pre-Clinical Studies to First in Human: What's New on the Horizon
Novel Anti-CD94 Treatment Reduces Kidney Ischemia-Reperfusion Injury and Subsequent Acute Lung Injury
Email:
info@wtc2025.org
514-874-1717
